{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:59:31Z","timestamp":1780984771421,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10067-026-08062-6","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:45:17Z","timestamp":1775195117000},"page":"3349-3354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the efficacy of various hepatitis B dosage regimens in spondyloarthritis patients undergoing immunomodulatory treatment"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2270-102X","authenticated-orcid":false,"given":"Gizem","family":"Varkal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5192-9045","authenticated-orcid":false,"given":"Ipek","family":"T\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2501-2473","authenticated-orcid":false,"given":"Elif Altunel","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0092-8645","authenticated-orcid":false,"given":"Gizem","family":"K\u0131rm\u0131z\u0131er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5662-8305","authenticated-orcid":false,"given":"Ferit","family":"Ku\u015f\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2081-4664","authenticated-orcid":false,"given":"Behice","family":"Kurtaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-8126","authenticated-orcid":false,"given":"S\u00fcleyman","family":"\u00d6zbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"8062_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82:19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"key":"8062_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020297","volume":"10","author":"B Garcill\u00e1n","year":"2022","unstructured":"Garcill\u00e1n B, Salavert M, Regueiro JR et al (2022) Response to vaccines in patients with immune-mediated inflammatory diseases: a narrative review. Vaccines 10:297. https:\/\/doi.org\/10.3390\/vaccines10020297","journal-title":"Vaccines"},{"key":"8062_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","volume":"79","author":"V Furer","year":"2020","unstructured":"Furer V, Rondaan C, Heijstek MW et al (2020) 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 79:39\u201352. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215882","journal-title":"Ann Rheum Dis"},{"key":"8062_CR4","volume-title":"Hepatitis B. Fact sheet","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024) Hepatitis B. Fact sheet. WHO, Geneva"},{"key":"8062_CR5","doi-asserted-by":"publisher","unstructured":"van Assen S, Agmon-Levin N, Elkayam O et al (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70:414\u2013422 https:\/\/doi.org\/10.1136\/ard.2010.137216","DOI":"10.1136\/ard.2010.137216"},{"key":"8062_CR6","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1093\/cid\/cit684","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P et al (2014) 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 58:e44-100. https:\/\/doi.org\/10.1093\/cid\/cit684","journal-title":"Clin Infect Dis"},{"key":"8062_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233corr1","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R et al (2009) ASAS classification criteria for axial spondyloarthritis (part II). Ann Rheum Dis 68:777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233corr1","journal-title":"Ann Rheum Dis"},{"key":"8062_CR8","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ajg.2012.79","volume":"107","author":"JP Gisbert","year":"2012","unstructured":"Gisbert JP, Villagrasa JR, Rodr\u00edguez-Nogueiras A et al (2012) Efficacy of hepatitis B vaccination in IBD. Am J Gastroenterol 107:1460\u20131466. https:\/\/doi.org\/10.1038\/ajg.2012.79","journal-title":"Am J Gastroenterol"},{"key":"8062_CR9","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/21645515.2019.1574151","volume":"15","author":"A Haykir Solay","year":"2019","unstructured":"Haykir Solay A, Eser S (2019) High-dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs. Hum Vaccin Immunother 15:1177\u20131182 1080\/21645515.2019.1574151","journal-title":"Hum Vaccin Immunother"},{"key":"8062_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.14309\/ajg.0000000000000921","volume":"115","author":"A Banty","year":"2020","unstructured":"Banty A, Melmed GY (2020) Improving HBV vaccination responses in IBD. Am J Gastroenterol 115:1797\u20131798. https:\/\/doi.org\/10.14309\/ajg.0000000000000921","journal-title":"Am J Gastroenterol"},{"key":"8062_CR11","doi-asserted-by":"publisher","unstructured":"Ocon AJ, Cooper S, Ramsey A, Mustafa S (2024) Secondary immunodeficiency and vaccine response in rheumatoid and psoriatic arthritis on immunosuppressive medicines. Cureus 16:e66366. https:\/\/doi.org\/10.7759\/cureus.66366","DOI":"10.7759\/cureus.66366"},{"key":"8062_CR12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jvh.13509","volume":"28","author":"S Rodr\u00edguez-Tajes","year":"2021","unstructured":"Rodr\u00edguez-Tajes S, Miralpeix A, Costa J et al (2021) Accelerated double-dose HBV vaccination in cirrhosis. J Viral Hepat 28:1019\u20131024. https:\/\/doi.org\/10.1111\/jvh.13509","journal-title":"J Viral Hepat"},{"key":"8062_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5152\/turkarchpediatr.2021.21090","volume":"56","author":"S Ocak","year":"2021","unstructured":"Ocak S, \u00d6zt\u00fcrk B, Karaman S et al (2021) Super-accelerated HBV vaccination in children with cancer. Turk Arch Pediatr 56:469\u2013473. https:\/\/doi.org\/10.5152\/turkarchpediatr.2021.21090","journal-title":"Turk Arch Pediatr"},{"key":"8062_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ibd\/izx001","volume":"24","author":"PK Pratt Jr","year":"2018","unstructured":"Pratt PK Jr, David N, Weber HC et al (2018) Antibody response to hepatitis B virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy. Inflamm Bowel Dis 24:380\u2013386 1093\/ibd\/izx001","journal-title":"Inflamm Bowel Dis"},{"key":"8062_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12040364","volume":"15","author":"M Shehab","year":"2024","unstructured":"Shehab M, Alrashed F, Alyaseen M et al (2024) Immunogenicity of hepatitis B vaccination in patients with ulcerative colitis on infliximab is attenuated compared to those on 5-aminosalicylic acid therapies: a prospective observational study. Vaccines 15:364. https:\/\/doi.org\/10.3390\/vaccines12040364","journal-title":"Vaccines"},{"key":"8062_CR16","first-page":"1712","volume":"8","author":"JS Nielsen","year":"2014","unstructured":"Nielsen JS, J\u00f8rgensen SM, Jensen VV et al (2014) Impaired response to hepatitis B vaccination in patients with inflammatory bowel disease. J Crohns Colitis 8:1712\u20131719","journal-title":"J Crohns Colitis"},{"key":"8062_CR17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.5152\/tjg.2018.17608","volume":"29","author":"R Altun","year":"2018","unstructured":"Altun R, Koruk ST (2018) The effectiveness of double-dose hepatitis B vaccination in patients with chronic inflammatory diseases using anti-TNF agents. Turk J Gastroenterol 29:555\u2013560","journal-title":"Turk J Gastroenterol"},{"key":"8062_CR18","first-page":"1248","volume":"92","author":"R Altun","year":"2020","unstructured":"Altun R, Koruk ST (2020) Comparison of standard and double-dose vaccination in patients on anti-TNF therapy. J Med Virol 92:1248\u20131253","journal-title":"J Med Virol"},{"key":"8062_CR19","first-page":"4615","volume":"31","author":"JG Ponce","year":"2013","unstructured":"Ponce JG, Mart\u00ednez-Hern\u00e1ndez J, Garc\u00eda-Lled\u00f3 A et al (2013) Hepatitis B vaccination in HIV-infected adults: a randomized trial of three sequential 40-\u03bcg doses. Vaccine 31:4615\u20134620","journal-title":"Vaccine"},{"key":"8062_CR20","first-page":"1198","volume":"29","author":"HS Lee","year":"2014","unstructured":"Lee HS, Jung SM, Kwok SK et al (2014) Low response to hepatitis B vaccination in patients with RA on anti-TNF agents. J Korean Med Sci 29:1198\u20131203","journal-title":"J Korean Med Sci"},{"key":"8062_CR21","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/jcm12041630","volume":"12","author":"GM Leone","year":"2023","unstructured":"Leone GM, Di Stefano G, Al-Saffar S et al (2023) Past, Present and (Foreseeable) Future of Biological AntiTNF Alpha Therapy. J Clin Med 12:1630. https:\/\/doi.org\/10.3390\/jcm12041630","journal-title":"J Clin Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08062-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08062-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08062-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:25:50Z","timestamp":1780982750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08062-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8062"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08062-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflicts of interest with respect to the authorship and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}